Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

被引:9
|
作者
Cho, Eun-Young [1 ]
Kemmet, Olga [1 ]
Frenken, Michael [1 ]
机构
[1] St Josef Krankenhaus Monheim, Dept Surg, D-40789 Monheim, Germany
关键词
Biliopancreatic diversion with duodenal switch; BPD-DS; Type 2 diabetes mellitus; Complete remission; Insulin; OBESE-PATIENTS; SENSITIVITY; GLUCOSE; RESISTANCE; SURGERY; TERM;
D O I
10.1159/000327037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rapid resolution of type 2 diabetes mellitus (T2DM) is a common feature after intestinal bypass surgery bypassing the duodenum and parts of the jejunum. However, the parameters determining the individual chance of remission are imprecisely defined. Methods: Biliopancreatic diversion with duodenal switch and sleeve gastrectomy (BPD-DS) was performed in n = 86 patients with T2DM (mean age 50 years, range 26-68, 51 females; BMI 47 kg/m(2), range 26-71). The patients were retrospectively divided into 4 groups according to the treatment modality and the duration of insulin treatment preoperatively: n = 18 patients were treated with oral antidiabetic drugs only (group 1); n = 32, n = 24, and n = 12 patients were treated with insulin for less than 5 years, for 5-10 years, and for more than 10 years (groups 2, 3, and 4), respectively. Results: At discharge from hospital, all patients of groups 1 and 2 were free of insulin usage, 30% and 75% of the patients of groups 3 and 4 used up to 48 units of insulin per day (mean 24, n = 16). After 1 year, only 4 patients of group 4 permanently required small amounts of insulin (mean 17 units per day) to keep blood glucose below 200 mg/dl. These 4 patients had been using insulin preoperatively for 13, 15, 22, and 25 years. In 3 of these 4 patients, fasting C-peptide was measured and found to be low (<1.2 ng/ml). The rate of complete remission of diabetes for the whole study population was 91%. Conclusion: BPD-DS reliably causes rapid and complete remission of T2DM in all patients on oral antidiabetic drugs and in patients with insulin treatment for less than 5 years. In patients with insulin treatment longer than 5 or 10 years, complete remission rates decline to 88 and 66%, respectively. A low C-peptide preoperatively might be a specific adverse prognostic parameter for the chance of diabetes remission.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [1] Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes Mellitus: is the Chance of Cure Dependent on Severity and Duration of the Disease?
    Tunger, S.
    Ingo, R.
    Frenken, M.
    OBESITY SURGERY, 2009, 19 (08) : 972 - 972
  • [2] BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH FOR THE SURGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH OBESITY
    Todurov, I.
    Bilianskyi, L.
    Perekhrestenko, O.
    Kalashnikov, O.
    Kosiukhno, S.
    Plehutsa, O.
    OBESITY SURGERY, 2014, 24 (08) : 1237 - 1237
  • [3] Resolution of Diabetes Mellitus Type 2 After Biliopancreatic Diversion/Duodenal Switch
    Nikolsky, A.
    Karpova, E.
    Bekuzarov, D.
    Sineokaya, M.
    OBESITY SURGERY, 2009, 19 (08) : 1004 - 1005
  • [4] Biliopancreatic Diversion with Duodenal Switch in the Treatment of Diabetes: An Argument that a Chance to Cut is a Chance to Cure
    Hussain, Mustafa
    Pomp, Alfons
    CANADIAN JOURNAL OF DIABETES, 2011, 35 (02) : 109 - 114
  • [5] Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch
    Kapeluto, Jordanna E.
    Tchernof, Andre
    Masckauchan, Daiana
    Biron, Simon
    Marceau, Simon
    Hould, Frederic-Simon
    Lebel, Stefane
    Lescelleur, Odette
    Julien, Francois
    Biertho, Laurent
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (11) : 1701 - 1712
  • [6] CARBOHYDRATE METABOLISM IN THE OBESE PATIENTS WITH DIABETES MELLITUS TYPE 2 AFTER BILIOPANCREATIC DIVERSION/DUODENAL SWITCH (BPD/DS)
    Yashkov, Y.
    Ershova, E.
    Troshina, E.
    OBESITY SURGERY, 2012, 22 (08) : 1183 - 1183
  • [7] Long-term Remission of Type 2 Diabetes and Patient Survival After Biliopancreatic Diversion with Duodenal Switch
    Frenken, Michael
    Kemmet, Olga
    Frenken, Miriam
    Roehrig, Ingo
    Fischer, Lars
    Hellinger, Achim
    OBESITY SURGERY, 2022, 32 (10) : 3340 - 3350
  • [8] Long-term Remission of Type 2 Diabetes and Patient Survival After Biliopancreatic Diversion with Duodenal Switch
    Michael Frenken
    Olga Kemmet
    Miriam Frenken
    Ingo Röhrig
    Lars Fischer
    Achim Hellinger
    Obesity Surgery, 2022, 32 : 3340 - 3350
  • [9] Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?
    Audrey Auclair
    Julie Martin
    Marjorie Bastien
    Nadine Bonneville
    Laurent Biertho
    Simon Marceau
    Frédéric-Simon Hould
    Simon Biron
    Stéfane Lebel
    Odette Lescelleur
    Jean-Pierre Després
    Paul Poirier
    Obesity Surgery, 2016, 26 : 1717 - 1727
  • [10] Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?
    Auclair, Audrey
    Martin, Julie
    Bastien, Marjorie
    Bonneville, Nadine
    Biertho, Laurent
    Marceau, Simon
    Hould, Frederic-Simon
    Biron, Simon
    Lebel, Stefane
    Lescelleur, Odette
    Despres, Jean-Pierre
    Poirier, Paul
    OBESITY SURGERY, 2016, 26 (08) : 1717 - 1727